Impact of monoclonal anti-CD38 antibody on collected myeloid and erythroid progenitor cells and clinical course of autologous stem cell transplant for patients with multiple myeloma

被引：0
|
作者：
Manjappa, Shivaprasad [1 ]
Eduafo, Augusta [2 ]
Fox, Robert [1 ]
Reese, Jane [1 ]
Schmikla, Hannah [1 ]
Kolk, Merle [1 ]
Driscoll, James [1 ]
Malek, Ehsan [3 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[2] St Johns Med Ctr, Westlake, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-026
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients
    Suzuki, Kazuhito
    Gunji, Tadahiro
    Nagao, Riku
    Kawashima, Masaharu
    Uryu, Hideki
    Momoki, Mamiko
    Ishii, Hiroto
    Fukushima, Ryoko
    Katori, Mitsuji
    Yokoyama, Hiroki
    Katsube, Atsushi
    Saito, Takeshi
    Nishiwaki, Kaichi
    Yano, Shingo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [42] OPTIMIZING CRYOPRESERVATION OF HEMATOPOIETIC STEM CELLS COLLECTED FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Turney, T. L.
    Reese-Koc, J.
    de Lima, M.
    Otegbeye, F.
    CYTOTHERAPY, 2019, 21 (05) : S39 - S39
  • [43] Efficacy and Safety of SelinexorContaining Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (aCD38 mAb)
    Lentzsch, Suzanne
    Lipe, Brea
    Tuchman, Sascha A.
    Bahlis, Nizar J.
    Bensinger, William I.
    Sebag, Michael
    Sutherland, Heather J.
    Monge, Jorge
    Gasparetto, Cristina J.
    Baljevic, Muhamed
    Callander, Natalie S.
    Venner, Christopher P.
    White, Darrell J.
    Kotb, Rami
    Chen, Christine I.
    Schiller, Gary J.
    Madan, Sumit
    Leblanc, Richard
    De Castro, Andrew
    Bentur, Ohad S.
    Shah, Jatin J.
    Van Domelen, Dane R.
    Kauffman, Michael G.
    Shacham, Sharon
    Biran, Noa
    BLOOD, 2021, 138
  • [44] Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy
    Venglar, Ondrej
    Kapustova, Veronika
    Anilkumar Sithara, Anjana
    Zihala, David
    Muronova, Ludmila
    Sevcikova, Tereza
    Vrana, Jan
    Vdovin, Alexander
    Radocha, Jakub
    Krhovska, Petra
    Hrdinka, Matous
    Turjap, Michal
    Popkova, Tereza
    Chyra, Zuzana
    Broskevicova, Lucie
    Simicek, Michal
    Koristek, Zdenek
    Hajek, Roman
    Jelinek, Tomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1439 - 1449
  • [45] ESTIMATING THE NUMBER OF MULTIPLE MYELOMA PATIENTS IN EUROPE WHO HAVE BEEN EXPOSED TO PROTEASOME INHIBITORS, IMMUNOMODULATORY DRUGS AND ANTI-CD38 MONOCLONAL ANTIBODY THERAPY
    Tamas, A.
    Nemeth, B.
    Erler, N.
    Csanadi, M.
    Bacon, T.
    VALUE IN HEALTH, 2020, 23 : S524 - S524
  • [46] Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma
    Kansagra, Ankit
    Gonsalves, Wilson, I
    Gertz, Morie A.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Kapoor, Prashant
    Muchtar, Eli
    Kourelis, Taxiarchis, V
    Warsame, Rahma
    Leung, Nelson
    Zeldenrust, Steven R.
    Lust, John A.
    Rajkumar, S. Vincent
    Kyle, Robert A.
    Hogan, William
    Kumar, Shaji K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (10) : 2127 - 2132
  • [47] Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma
    Martin, Thomas G.
    Shah, Nina
    Richter, Joshua
    Vesole, David H.
    Wong, Sandy W.
    Huang, Chiung-Yu
    Madduri, Deepu
    Jagannath, Sundar
    Siegel, David S.
    Biran, Noa
    Wolf, Jeffrey L.
    Parekh, Samir
    Cho, Hearn J.
    Munster, Pamela
    Richard, Shambavi
    Ziti-Ljajic, Samira
    Chari, Ajai
    CANCER, 2021, 127 (11) : 1816 - 1826
  • [48] Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant
    Pasvolsky, Oren
    Saliba, Rima M.
    Masood, Adeel
    Mohamedi, Ali H.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : E37 - E41
  • [49] Impact of Obesity on Outcomes of Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplant
    Marcoux, Curtis
    Pasyar, Sarah
    Milton, Denai
    Khan, Hina
    Tanner, Mark
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Neupane, Niraj
    Lee, Hans
    Patel, Krina
    Tang, Guilin
    Lee, Jaehyun
    Aljawai, Yosra
    Kebriaei, Partow
    Thomas, Sheeba
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard
    Qazilbash, Muzaffar
    Pasvolsky, Oren
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S236 - S236
  • [50] Outcomes of Patients with Relapsed Multiple Myeloma Treated with Pomalidomide, Cyclophosphamide, and Dexamethasone Based on Prior Resistance to Anti-CD38 Monoclonal Antibodies
    Hidalgo-Soto, Marta
    Martin-Rodriguez, Lucia
    Montreal, Eugenia Abella
    Fernandez-Camacho, Inmaculada
    Mesa, Mercedes Gironella
    Gonzalez-Montes, Yolanda
    Lopez, M. Teresa Cibeira
    Dachs, Laura Rosinol
    Perez, Jose Miguel Mateos
    Tovar, Natalia
    Larrea, Carlos Fernandez de
    Rodriguez-Lobato, Luis Gerardo
    BLOOD, 2024, 144 : 6955 - 6956
12345